July 2016

Increased adoption of Impella heart pumps helps raise Abiomed’s quarterly revenue ()
Theranos CEO Elizabeth Holmes to speak at clinical chemistry conference ()
Mediterranean diet may improve cardiovascular outcomes ()
After a stroke, patients have increased risk of recurrent stroke, dementia ()
Female cardiologist in Maryland is 75 and still working 12-hour days ()
Boston Scientific posts sales increase in 2nd quarter, raises revenue guidance ()
Study on Apollo astronauts links deep space radiation to cardiovascular diseases ()
ACC, AHA comment on proposed bundled payments for cardiac care ()
Physical activity may lower coronary heart disease risk in younger women ()
Bristol-Myers Squibb settles whistleblower lawsuit for $30 million ()
Heart failure patients receiving sacubitril/valsartan have reduction in 30-day readmissions ()
CMS star ratings debut with promise for continued updates ()
TAVR growth helps Edwards post strong second quarter financial results ()
Patients with heart failure and improved or recovered ejection fraction may have improved outcomes ()
Shortage of donor hearts creates issues for physicians ()
With Abbott deal near completion, St. Jude Medical’s sales increase 11% ()
Flu vaccines associated with 24 percent all-cause death reduction in type 2 diabetes patients ()
CMS proposes bundled payments model for cardiac care ()
Abbott’s revenue increases 3.2% in second quarter ()
Heart transplant recipient becomes long distance runner ()
Endocrinologist responds to study suggesting low sodium intake may increase cardiovascular events ()
Meta-analysis finds no significant difference in mortality risk between diabetes medications ()
Cardiac Science releases new CPR support device ()
Texas health system opens cardiovascular center in response to study ()
Stryker recalls 167 angiographic catheters ()
Providence Health Care Becomes First Canadian Center to Adopt Revolutionary HeartFlow FFRct Analysis to Assess Coronary Artery Disease ()
Madrigal, Synta complete merger ()
Medicare selects participants for new five-year cardiovascular initiative ()
Theranos hires executives, creates committee to oversee regulatory compliance ()
New research suggests cardiovascular mortality could be affected by the color of your skin ()
Surgeon specialization may predict 30-day operative mortality following cardiac procedures ()
FDA approves the Celt ACD vascular closure device ()
FDA approves generic versions of Crestor ()
CMS announces 516 participating organizations in program to reduce risk of MIs and strokes ()
PCORI provides $6.5 million in funding for comparative effectiveness research for anticoagulants ()
More than 17 percent of adolescents have prediabetes ()
Judge denies AstraZeneca’s request for exclusivity to sell blockbuster cholesterol medication ()
Systematic review finds evidence is lacking for percutaneous LAA exclusion as an alternative to oral anticoagulation ()
Adults who eat more subsidized foods may have an increase in cardiometabolic risk ()
Mortality rate remains high in patients undergoing PCI for an MI following noncardiac surgery ()
Mitral valve repair device 100 percent successful in first human clinical study ()
Fewer than 1/3 of eligible patients participate in cardiac rehabilitation programs ()
Novartis plans to invest $200 million this year to increase sales of heart failure medication ()
Bleeding risk associated with vitamin K antagonists only slightly increases past age 80 ()
Edwards names Leslie Heisz to board of directors ()
Scoring system may help predict 30-day and one-year mortality following TAVR ()
Palliative care is uncommon among heart failure patients ()
Penn Medicine study shows side effects of breast cancer drug ()
Study: More than 90 percent of strokes are preventable ()
Obese adults see improvements in blood pressure, cholesterol levels but worsening blood glucose health ()
USPSTF outlines research plan for examining the use of ECG to screen for CVD risk and atrial fibrillation ()
Federal court dismisses lawsuit, upholds settlement between Cardiovascular Systems and ex-salesman ()
Corpath System to be Featured for Complex Interventions at SDCI 2016: San Diego Cardiovascular Interventions Course ()
Medtronic Receives FDA Approval for IN.PACT Admiral DCB 150 mm Lengths ()
University of Chicago Medicine Creating High-Tech Arrhythmia Technology Suite with Stereotaxis Niobe® ES System ()
Good Samaritan Hospital First on the West Coast to Offer Naturally Dissolving Heart Stent to Patients with Coronary Artery Disease ()
Trial examines the Tryton stent for use in patients with large side branches ()
First Coast's Proposed Cut In Reimbursement Rate Of Blood Test Threatens Heart Transplant Patient Care In Florida ()
Endotronix closes Series C round funding for development of artery sensor ()
Cardiologist Galen Wagner dies at age 76 ()
CMS grants IDE to MedStar for trial examining TAVR devices ()
Patients who develop heart failure after first MI have an increased risk of cancer ()
New research finds collagen to be tissue remodeling regulator ()
FDA approves system that provides once monthly dose of Amgen’s PCSK9 inhibitor ()
New transcatheter system boosts outlook for aortic stenosis patients, study suggests ()
Ex-Valeant CEO sells shares for nearly $100 million ()
FDA approves Medtronic’s drug-coated balloon in a longer length ()
New study shows atrial fibrillation related to smaller brain volumes ()
Alere recalls its PT/INR monitoring system ()
Boston Scientific elects former Lixil CEO to its board of directors ()
AHA releases list of drugs that may cause or exacerbate heart failure ()
Immunotherapy reduces cardiovascular risk in patients with rheumatoid arthritis ()
Advance care planning video helps heart failure patients make informed decisions ()
FDA approves St. Jude Medical’s CRT software ()
Involving pharmacists in care decisions may reduce risk of cardiovascular disease ()
Mednax acquires Pediatric Cardiology Associates in cash deal ()
Report says Theranos CEO’s role will likely remain the same ()
AHA, Amazon collaborate on precision medicine initiative ()
Bernie Sanders, House Democrats urge FDA to approve generic versions of Crestor ()
Harvard researchers hope artificial stingray can help them engineer a human heart ()
ABIM appoints 10 cardiologists to specialty boards and exam committees ()
BayCare Health first to implant world’s smallest pacemaker ()
Pharmacist intervention in Canada reduces risk of cardiovascular events ()
Arizona marathon runner receives first dissolvable heart stent ()
Essential Medical gets FDA approval for vascular closure trial ()
CMS sanctions Theranos, prohibits CEO from operating a lab for two years ()
The presence of anemia in chronic heart failure patients worsens outcomes ()
Sudden cardiac death is more common in men than women ()
Cardiologist urges colleagues to vote for Donald Trump ()
Cardiologists claim PCIs may not be appropriate to treat stable ischemic heart disease ()
Registry analysis finds physicians prescribe oral anticoagulants at lower rate than expected ()
Prevalence of people living with congenital heart defects increases 40% from 2000 to 2010 ()
Investigational PCSK9 inhibitor significantly reduces LDL cholesterol in phase 3 trials ()
Valeant’s stock price continues to decrease under new CEO ()
Shortage of technetium Tc 99m leads to decrease in cardiac stress testing ()
Stentys hires Christophe Lottin as CEO ()
FDA approves Absorb, Abbott’s fully bioresorbable drug-eluting stent ()
Federal government indicts Kentucky cardiologist ()
AHA honors three longtime volunteers with the Gold Heart Award ()
Esperion Therapeutics’ shares fall after disclosing uncertain future for its cholesterol-lowering drug ()
Florida cardiologist settles with the DOJ, agrees to pay $2 million fine ()
Study: Young black athletes die of hypertrophic cardiomyopathy more than other subgroups ()
Analyses show cost-effectiveness, value of oral heart failure medication ()